Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review

Respiratory Medicine

Volumn 109, Issue 11, 2015, Pages 1371-1380

  Lahousse, Lies ^a,b   Tiemeier, Henning ^b   Ikram, M Arfan ^b   Brusselle, Guy G ^a,b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cerebral small vessel disease; Cerebrovascular disease; Chronic obstructive pulmonary disease; Cognitive impairment; Stroke

Indexed keywords

AGING; BLOOD VESSEL REACTIVITY; BRAIN FUNCTION; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITION; DEMENTIA; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; HYPOXIA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SMOKING; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COMORBIDITY; MEDICAL RESEARCH; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; STROKE; TRENDS;

BIOMEDICAL RESEARCH; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COMORBIDITY; DEMENTIA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; STROKE;

EID: 84947045603     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.07.014     Document Type: Review

References (141)

1. P.J. Magistretti, and L. Pellerin Cellular mechanisms of brain energy metabolism. relevance to functional brain imaging and to neurodegenerative disorders Ann. N. Y. Acad. Sci. 777 1996 Jan 17 380 387
2. N.A. Bishop, T. Lu, and B.A. Yankner Neural mechanisms of ageing and cognitive decline Nature 464 7288 2010 Mar 25 529 535
3. E. Sibille Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders Dialogues Clin. Neurosci. 15 1 2013 Mar 53 65
4. H.U. Wittchen, and F. Jacobi Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies Eur. Neuropsychopharmacol. 15 4 2005 Aug 357 376
5. J. Vestbo, S.S. Hurd, A.G. Agusti, P.W. Jones, C. Vogelmeier, A. Anzueto, and et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am. J. Respir. Crit. Care Med. 187 4 2013 Feb 15 347 365
6. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, and et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010 Lancet 380 9859 2012 Dec 15 2095 2128
7. J.W. Dodd, S.V. Getov, and P.W. Jones Cognitive function in COPD Eur. Respir. J. 35 4 2010 Apr 913 922
8. K.M. Hynninen, M.H. Breitve, A.B. Wiborg, S. Pallesen, and I.H. Nordhus Psychological characteristics of patients with chronic obstructive pulmonary disease: a review J. Psychosom. Res. 59 6 2005 Dec 429 443
9. J.R. Feary, L.C. Rodrigues, C.J. Smith, R.B. Hubbard, and J.E. Gibson Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care Thorax 65 11 2010 956 962
10. L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges Lancet Neurol. 9 7 2010 Jul 689 701
11. S.M. Greenberg, M.W. Vernooij, C. Cordonnier, A. Viswanathan, R. Al-Shahi Salman, S. Warach, and et al. Cerebral microbleeds: a guide to detection and interpretation Lancet Neurol. 8 2 2009 Feb 165 174
12. M.M. Poels, M.A. Ikram, A. van der Lugt, A. Hofman, G.P. Krestin, M.M. Breteler, and et al. Incidence of cerebral microbleeds in the general population: the rotterdam scan study Stroke 42 3 2011 Mar 656 661
13. Y. Taki, S. Kinomura, S. Ebihara, B. Thyreau, K. Sato, R. Goto, and et al. Correlation between pulmonary function and brain volume in healthy elderly subjects Neuroradiology 55 6 2013 Jun 689 695
14. D. Liao, M. Higgins, N.R. Bryan, M.L. Eigenbrodt, L.E. Chambless, V. Lamar, and et al. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the atherosclerosis risk in communities study Chest 116 1 1999 Jul 150 156
15. J.W. Dodd, A.W. Chung, M.D. van den Broek, T.R. Barrick, R.A. Charlton, and P.W. Jones Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study Am. J. Respir. Crit. Care Med. 186 3 2012 Aug 1 240 245
16. E.J. van Dijk, S.E. Vermeer, J.C. de Groot, J. van de Minkelis, N.D. Prins, M. Oudkerk, and et al. Arterial oxygen saturation, COPD, and cerebral small vessel disease J. Neurol. Neurosurg. Psychiatry 75 5 2004 May 733 736
17. L. Lahousse, M.W. Vernooij, S.K. Darweesh, S. Akoudad, D.W. Loth, G.F. Joos, and et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The rotterdam study Am. J. Respir. Crit. Care Med. 188 7 2013 Oct 1 783 788
18. M.W. Vernooij, A. van der Lugt, M.A. Ikram, P.A. Wielopolski, W.J. Niessen, A. Hofman, and et al. Prevalence and risk factors of cerebral microbleeds: the rotterdam scan study Neurology 70 14 2008 Apr 1 1208 1214
19. K. Aho, P. Harmsen, S. Hatano, J. Marquardsen, V.E. Smirnov, and T. Strasser Cerebrovascular disease in the community: results of a WHO collaborative study Bull. World Health Organ 58 1 1980 113 130
20. J.D. Easton, J.L. Saver, G.W. Albers, M.J. Alberts, S. Chaturvedi, E. Feldmann, and et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American heart association/American stroke association stroke council; council on cardiovascular surgery and anesthesia; council on cardiovascular radiology and intervention; council on cardiovascular nursing; and the interdisciplinary council on peripheral vascular disease. The american academy of neurology affirms the value of this statement as an educational tool for neurologists Stroke 40 6 2009 Jun 2276 2293
21. S.G. Wannamethee, A.G. Shaper, and S. Ebrahim Respiratory function and risk of stroke Stroke 26 11 1995 Nov 2004 2010
22. D.J. Hole, G.C. Watt, G. Davey-Smith, C.L. Hart, C.R. Gillis, and V.M. Hawthorne Impaired lung function and mortality risk in men and women: findings from the renfrew and paisley prospective population study BMJ 313 7059 1996 Sep 21 711 715
23. A.K. Gulsvik, A. Gulsvik, E. Skovlund, D.S. Thelle, M. Mowe, S. Humerfelt, and et al. The association between lung function and fatal stroke in a community followed for 4 decades J. Epidemiol. Community Health 66 11 2012 Nov 1030 1036
24. D.P. Strachan Ventilatory function as a predictor of fatal stroke Bmj 302 6768 1991 Jan 12 84 87
25. A. Hozawa, J.L. Billings, E. Shahar, T. Ohira, W.D. Rosamond, and A.R. Folsom Lung function and ischemic stroke incidence: the atherosclerosis risk in communities study Chest 130 6 2006 Dec 1642 1649
26. T. Truelsen, E. Prescott, P. Lange, P. Schnohr, and G. Boysen Lung function and risk of fatal and non-fatal stroke. The copenhagen city heart study Int. J. Epidemiol. 30 1 2001 Feb 145 151
27. S.M. Curkendall, C. DeLuise, J.K. Jones, S. Lanes, M.R. Stang, E. Goehring Jr., and et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, saskatchewan Canada cardiovascular disease in COPD patients Ann. Epidemiol. 16 1 2006 Jan 63 70
28. C. Schneider, U. Bothner, S.S. Jick, and C.R. Meier Chronic obstructive pulmonary disease and the risk of cardiovascular diseases Eur. J. Epidemiol. 25 4 2010 Apr 253 260
29. J. Finkelstein, E. Cha, and S.M. Scharf Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity Int. J. Chron. Obstruct Pulmon Dis. 4 2009 337 349
30. H. Iwamoto, A. Yokoyama, Y. Kitahara, N. Ishikawa, Y. Haruta, K. Yamane, and et al. Airflow limitation in smokers is associated with subclinical atherosclerosis Am. J. Respir. Crit. Care Med. 179 1 2009 Jan 1 35 40
31. R.G. Barr, F.S. Ahmed, J.J. Carr, E.A. Hoffman, R. Jiang, S.M. Kawut, and et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA lung study Eur. Respir. J. 39 4 2012 Oct 27 846 854
32. L. Lahousse, Q. van den Bouwhuijsen, D.W. Loth, G.F. Joos, A. Hofman, J.C. Witteman, and et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the rotterdam study Am. J. Respir. Crit. Care Med. 187 1 2013 Nov 9 58 64
33. F.A. Cleutjens, D.J. Janssen, R.W. Ponds, J.B. Dijkstra, and E.F. Wouters COgnitive-pulmonary disease Biomed. Res. Int. 2014 2014 697825
34. L. Lahousse, V.J. Verlinden, J.N. van der Geest, G.F. Joos, A. Hofman, B.H. Stricker, and et al. Gait patterns in COPD: the rotterdam study Eur. Respir. J. 46 1 2015 Jul 88 95
35. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch. Neurol. 56 3 1999 Mar 303 308
36. J. Bischkopf, A. Busse, and M.C. Angermeyer Mild cognitive impairment-a review of prevalence, incidence and outcome according to current approaches Acta Psychiatr. Scand. 106 6 2002 Dec 403 414
37. L. Schou, B. Ostergaard, L.S. Rasmussen, S. Rydahl-Hansen, and K. Phanareth Cognitive dysfunction in patients with chronic obstructive pulmonary disease-a systematic review Respir. Med. 106 8 2012 Aug 1071 1081
38. R. Antonelli-Incalzi, A. Corsonello, C. Pedone, L. Trojano, D. Acanfora, A. Spada, and et al. Drawing impairment predicts mortality in severe COPD Chest 130 6 2006 Dec 1687 1694
39. R.A. Incalzi, A. Gemma, C. Marra, R. Muzzolon, O. Capparella, and P. Carbonin Chronic obstructive pulmonary disease. An original model of cognitive decline Am. Rev. Respir. Dis. 148 2 1993 Aug 418 424
40. I. Grant, R.K. Heaton, A.J. McSweeny, K.M. Adams, and R.M. Timms Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease Arch. Intern Med. 142 8 1982 Aug 1470 1476
41. I. Grant, G.P. Prigatano, R.K. Heaton, A.J. McSweeny, E.C. Wright, and K.M. Adams Progressive neuropsychologic impairment and hypoxemia. Relationship in chronic obstructive pulmonary disease Arch. Gen. Psychiatry 44 11 1987 Nov 999 1006
42. D.T. Stuss, I. Peterkin, D.A. Guzman, C. Guzman, and A.K. Troyer Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures J. Clin. Exp. Neuropsychol. 19 4 1997 Aug 515 524
43. S. Villeneuve, V. Pepin, S. Rahayel, J.A. Bertrand, M. de Lorimier, A. Rizk, and et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study Chest 142 6 2012 Dec 1516 1523
44. B. Singh, M.M. Mielke, A.K. Parsaik, R.H. Cha, R.O. Roberts, P.D. Scanlon, and et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment JAMA Neurol. 71 5 2014 May 581 588
45. F.A. Cleutjens, M.A. Spruit, J. Beckervordersandforth, F.M. Franssen, J.B. Dijkstra, R.W. Ponds, and et al. Presence of brain pathology in deceased subjects with and without chronic obstructive pulmonary disease Chron. Respir. Dis. 2015 May 31
46. M. Rusanen, T. Ngandu, T. Laatikainen, J. Tuomilehto, H. Soininen, and M. Kivipelto Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study Curr. Alzheimer Res. 10 5 2013 Jun 549 555
47. C.H. Li, W.C. Chen, W.C. Liao, C.Y. Tu, C.L. Lin, F.C. Sung, and et al. The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study QJM 108 1 2015 Jan 39 45
48. L. Pezzoli, G. Giardini, S. Consonni, I. Dallera, C. Bilotta, G. Ferrario, and et al. Quality of spirometric performance in older people Age ageing 32 1 2003 Jan 43 46
49. V. Bellia, R. Pistelli, F. Catalano, R. Antonelli-Incalzi, V. Grassi, G. Melillo, and et al. Quality control of spirometry in the elderly. The SA.R.A. study. Salute respiration nell'anziano = respiratory health in the elderly Am. J. Respir. Crit. care Med. 161 4 Pt 1 2000 Apr 1094 1100
50. J.D. Maclay, D.A. McAllister, N.L. Mills, F.P. Paterson, C.A. Ludlam, E.M. Drost, and et al. Vascular dysfunction in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 180 6 2009 Sep 15 513 520
51. M.M. Poels, M.W. Vernooij, M.A. Ikram, A. Hofman, G.P. Krestin, A. van der Lugt, and et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study Stroke 41 10 Suppl 2010 Oct S103 S106
52. T.B. Kirkwood Understanding the odd science of aging Cell. 120 4 2005 Feb 25 437 447
53. A. Clegg, J. Young, S. Iliffe, M.O. Rikkert, and K. Rockwood Frailty in elderly people Lancet 381 9868 2013 Mar 2 752 762
54. K. Ito, and P.J. Barnes COPD as a disease of accelerated lung aging Chest 135 1 2009 Jan 173 180
55. C. Lopez-Otin, M.A. Blasco, L. Partridge, M. Serrano, and G. Kroemer The hallmarks of aging Cell. 153 6 2013 Jun 6 1194 1217
56. L. Rode, S.E. Bojesen, M. Weischer, J. Vestbo, and B.G. Nordestgaard Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals Thorax 68 5 2013 May 429 435
57. W.E. Balch, J.I. Sznajder, S. Budinger, D. Finley, A.D. Laposky, A.M. Cuervo, and et al. Malfolded protein structure and proteostasis in lung diseases Am. J. Respir. Crit. Care Med. 189 1 2014 Jan 1 96 103
58. X. Zhang, B.J. Salmeron, T.J. Ross, X. Geng, Y. Yang, and E.A. Stein Factors underlying prefrontal and insula structural alterations in smokers Neuroimage 54 1 2011 Jan 1 42 48
59. A.L. Brody, M.A. Mandelkern, M.E. Jarvik, G.S. Lee, E.C. Smith, J.C. Huang, and et al. Differences between smokers and nonsmokers in regional gray matter volumes and densities Biol. Psychiatry 55 1 2004 Jan 1 77 84
60. X. Zhang, B.J. Salmeron, T.J. Ross, H. Gu, X. Geng, Y. Yang, and et al. Anatomical differences and network characteristics underlying smoking cue reactivity Neuroimage 54 1 2011 Jan 1 131 141
61. R. Yu, L. Zhao, and L. Lu Regional grey and white matter changes in heavy male smokers PLoS One 6 11 2011 e27440
62. J. Gallinat, E. Meisenzahl, L.K. Jacobsen, P. Kalus, J. Bierbrauer, T. Kienast, and et al. Smoking and structural brain deficits: a volumetric MR investigation Eur. J. Neurosci. 24 6 2006 Sep 1744 1750
63. S. Kuhn, F. Schubert, and J. Gallinat Reduced thickness of medial orbitofrontal cortex in smokers Biol. Psychiatry 68 11 2010 Dec 1 1061 1065
64. R.A. Gons, A.G. van Norden, K.F. de Laat, L.J. van Oudheusden, I.W. van Uden, M.P. Zwiers, and et al. Cigarette smoking is associated with reduced microstructural integrity of cerebral white matter Brain 134 Pt 7 2011 Jul 2116 2124
65. A. Ott, K. Andersen, M.E. Dewey, L. Letenneur, C. Brayne, J.R. Copeland, and et al. Effect of smoking on global cognitive function in nondemented elderly Neurology 62 6 2004 Mar 23 920 924
66. P.S. Sachdev, K.J. Anstey, R.A. Parslow, W. Wen, J. Maller, R. Kumar, and et al. Pulmonary function, cognitive impairment and brain atrophy in a middle-aged community sample Dement. Geriatr. Cogn. Disord. 21 5-6 2006 300 308
67. M. Richards, D. Strachan, R. Hardy, D. Kuh, and M. Wadsworth Lung function and cognitive ability in a longitudinal birth cohort study Psychosom. Med. 67 4 2005 Jul-Aug 602 608
68. K.J. Anstey, C. von Sanden, A. Salim, and R. O'Kearney Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies Am. J. Epidemiol. 166 4 2007 Aug 15 367 378
69. G.E. Swan, and C.N. Lessov-Schlaggar The effects of tobacco smoke and nicotine on cognition and the brain Neuropsychol. Rev. 17 3 2007 Sep 259 273
70. U. Wullner, D. Gundisch, H. Herzog, M. Minnerop, A. Joe, M. Warnecke, and et al. Smoking upregulates alpha4beta2∗nicotinic acetylcholine receptors in the human brain Neurosci. Lett. 430 1 2008 Jan 3 34 37
71. J.R. Turner, and K.J. Kellar Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes J. Neurosci. 25 40 2005 Oct 5 9258 9265
72. S. Borson, J. Scanlan, S. Friedman, E. Zuhr, J. Fields, E. Aylward, and et al. Modeling the impact of COPD on the brain Int. J. Chron. Obstruct Pulmon Dis. 3 3 2008 429 434
73. S.D. Friedman, C.A. Stidley, W.M. Brooks, B.L. Hart, and W.L. Sibbitt Brain injury and neurometabolic abnormalities in systemic lupus erythematosus Radiology 209 1 1998 Oct 79 84
74. S.D. Friedman, W.M. Brooks, R.E. Jung, S.J. Chiulli, J.H. Sloan, B.T. Montoya, and et al. Quantitative proton MRS predicts outcome after traumatic brain injury Neurology 52 7 1999 Apr 22 1384 1391
75. B. Ross, and T. Michaelis Clinical-applications of magnetic-resonance spectroscopy Magn. Reson. Q. 10 4 1994 Dec 191 247
76. J. Li, Y. Huang, and G.H. Fei The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease Respiration 85 2 2013 98 105
77. E.M. Schrijvers, P.J. Koudstaal, A. Hofman, and M.M. Breteler Plasma clusterin and the risk of Alzheimer disease JAMA 305 13 2011 Apr 6 1322 1326
78. K.S. Kendler, M.C. Neale, C.J. MacLean, A.C. Heath, L.J. Eaves, and R.C. Kessler Smoking and major depression. A causal analysis Arch. Gen. Psychiatry 50 1 1993 Jan 36 43
79. T. Ishii, R. Wakabayashi, H. Kurosaki, A. Gemma, and K. Kida Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms J. Hum. Genet. 56 1 2011 Jan 41 46
80. D.M. Chuang, Y. Leng, Z. Marinova, H.J. Kim, and C.T. Chiu Multiple roles of HDAC inhibition in neurodegenerative conditions Trends Neurosci. 32 11 2009 Nov 591 601
81. P.J. Barnes, I.M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J. 25 3 2005 Mar 552 563
82. M. Traylor, M. Farrall, E.G. Holliday, C. Sudlow, J.C. Hopewell, Y.C. Cheng, and et al. Genetic risk factors for ischaemic stroke and its subtypes (the metastroke collaboration): a meta-analysis of genome-wide association studies Lancet Neurol. 11 11 2012 Nov 951 962
83. C. Bellenguez, S. Bevan, A. Gschwendtner, C.C. Spencer, A.I. Burgess, M. Pirinen, and et al. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke Nat. Genet. 44 3 2012 Mar 328 333
84. S. Rajendrasozhan, S.R. Yang, V.L. Kinnula, and I. Rahman SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 177 8 2008 Apr 15 861 870
85. L. Guarente Sirtuins, aging, and medicine N. Engl. J. Med. 364 23 2011 Jun 9 2235 2244
86. M. Decramer, and W. Janssens Chronic obstructive pulmonary disease and comorbidities Lancet Respir. Med. 1 2013 73 83
87. J.W. Hwang, I.K. Sundar, H. Yao, M.T. Sellix, and I. Rahman Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway FASEB J. 28 1 2014 Jan 176 194
88. H. Zhou, Y. Wu, Y. Jin, J. Zhou, C. Zhang, L. Che, and et al. Genetic polymorphism of matrix metalloproteinase family and chronic obstructive pulmonary disease susceptibility: a meta-analysis Sci. Rep. 3 2013 2818
89. M. Ram, Y. Sherer, and Y. Shoenfeld Matrix metalloproteinase-9 and autoimmune diseases J. Clin. Immunol. 26 4 2006 Jul 299 307
90. J.C. Adair, J. Charlie, J.E. Dencoff, J.A. Kaye, J.F. Quinn, R.M. Camicioli, and et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease Stroke 35 6 2004 Jun e159 e162
91. J.M. Wardlaw, C. Smith, and M. Dichgans Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging Lancet Neurol. 12 5 2013 May 483 497
92. A.J. Wardlaw, C. Guillen, and A. Morgan Mechanisms of T cell migration to the lung Clin. Exp. Allergy 35 1 2005 Jan 4 7
93. F. Odoardi, C. Sie, K. Streyl, V.K. Ulaganathan, C. Schlager, D. Lodygin, and et al. T cells become licensed in the lung to enter the central nervous system Nature 488 7413 2012 Aug 30 675 679
94. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 2 1999 Jan 14 115 126
95. M.M. Poels, K. Zaccai, G.C. Verwoert, M.W. Vernooij, A. Hofman, A. van der Lugt, and et al. Arterial stiffness and cerebral small vessel disease: the rotterdam scan study Stroke 43 10 2012 Oct 2637 2642
96. R. Rodriguez-Roisin, S. Llufriu, and L.M. Fabbri Changes in your breathing can change your brain Am. J. Respir. Crit. Care Med. 188 7 2013 Oct 1 763 764
97. L.M. Fabbri, F. Luppi, B. Beghe, and K.F. Rabe Complex chronic comorbidities of COPD Eur. Respir. J. 31 1 2008 Jan 204 212
98. J.D. Maclay, and W. MacNee Cardiovascular disease in COPD: mechanisms Chest 143 3 2013 Mar 798 807
99. D.D. Sin, N.R. Anthonisen, J.B. Soriano, and A.G. Agusti Mortality in COPD: role of comorbidities Eur. Respir. J. 28 6 2006 Dec 1245 1257
100. D.D. Sin, and W. MacNee Chronic obstructive pulmonary disease and cardiovascular diseases: a "vulnerable" relationship Am. J. Respir. Crit. Care Med. 187 1 2013 Jan 1 2 4
101. A. Agusti, L.D. Edwards, S.I. Rennard, W. MacNee, R. Tal-Singer, B.E. Miller, and et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype PLoS One 7 5 2012 e37483
102. M.D. Eisner, P.D. Blanc, E.H. Yelin, S. Sidney, P.P. Katz, L. Ackerson, and et al. COPD as a systemic disease: impact on physical functional limitations Am. J. Med. 121 9 2008 Sep 789 796
103. R.N. Kalaria, R. Akinyemi, and M. Ihara Does vascular pathology contribute to Alzheimer changes? J. Neurol. Sci. 322 1-2 2012 Nov 15 141 147
104. H.B. Posner, M.X. Tang, J. Luchsinger, R. Lantigua, Y. Stern, and R. Mayeux The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function Neurology 58 8 2002 Apr 23 1175 1181
105. G.S. Alexopoulos, B.S. Meyers, R.C. Young, S. Campbell, D. Silbersweig, and M. Charlson 'Vascular depression' hypothesis Arch. Gen. Psychiatry 54 10 1997 Oct 915 922
106. K.R. Krishnan, J.C. Hays, and D.G. Blazer MRI-defined vascular depression Am. J. Psychiatry 154 4 1997 Apr 497 501
107. D.C. Steffens, W.D. Taylor, and K.R. Krishnan Progression of subcortical ischemic disease from vascular depression to vascular dementia Am. J. Psychiatry 160 10 2003 Oct 1751 1756
108. H. Ortapamuk, and S. Naldoken Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment Ann. Nucl. Med. 20 2 2006 Feb 99 106
109. E.K. Pae, P. Chien, and R.M. Harper Intermittent hypoxia damages cerebellar cortex and deep nuclei Neurosci. Lett. 375 2 2005 Feb 28 123 128
110. R. Hausmann, S. Seidl, and P. Betz Hypoxic changes in Purkinje cells of the human cerebellum Int. J. Leg. Med. 121 3 2007 May 175 183
111. R. Mathur, I.J. Cox, A. Oatridge, D.T. Shephard, R.J. Shaw, and S.D. Taylor-Robinson Cerebral bioenergetics in stable chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 160 6 1999 Dec 1994 1999
112. R. Gonzalvo, O. Marti-Sistac, L. Blanch, and J. Lopez-Aguilar Bench-to-bedside review: brain-lung interaction in the critically ill - a pending issue revisited Crit. Care 11 3 2007
113. J. Li, and G.H. Fei The unique alterations of hippocampus and cognitive impairment in chronic obstructive pulmonary disease Respir. Res. 14 2014 140
114. V.E. Ezeugwu, M. Olaogun, C.E. Mbada, and R. Adedoyin Comparative lung function performance of stroke survivors and age-matched and sex-matched controls Physiother. Res. Int. 18 4 2013 Dec 212 219
115. E.M. Khedr, O. El Shinawy, T. Khedr, Y. Abdel aziz ali, and E.M. Awad Assessment of corticodiaphragmatic pathway and pulmonary function in acute ischemic stroke patients Eur. J. Neurol. 7 5 2000 Sep 509 516
116. R. Martino, N. Foley, S. Bhogal, N. Diamant, M. Speechley, and R. Teasell Dysphagia after stroke: incidence, diagnosis, and pulmonary complications Stroke 36 12 2005 Dec 2756 2763
117. S. Artero, J. Touchon, and K. Ritchie Disability and mild cognitive impairment: a longitudinal population-based study Int. J. Geriatr. Psychiatry 16 11 2001 Nov 1092 1097
118. R. Antonelli-Incalzi, A. Corsonello, L. Trojano, D. Acanfora, A. Spada, O. Izzo, and et al. Correlation between cognitive impairment and dependence in hypoxemic COPD J. Clin. Exp. Neuropsychol. 30 2 2008 Feb 141 150
119. A.J. McSweeny, I. Grant, R.K. Heaton, G.P. Prigatano, and K.M. Adams Relationship of neuropsychological status to everyday functioning in healthy and chronically ill persons J. Clin. Exp. Neuropsychol. 7 3 1985 Jun 281 291
120. M. Carone, G. Bertolotti, F. Anchisi, A.M. Zotti, C.F. Donner, and P.W. Jones Analysis of factors that characterize health impairment in patients with chronic respiratory failure. quality of life in chronic respiratory failure group Eur. Respir. J. 13 6 1999 Jun 1293 1300
121. S.E. Campbell, D.G. Seymour, and W.R. Primrose A systematic literature review of factors affecting outcome in older medical patients admitted to hospital Age Ageing 33 2 2004 Mar 110 115
122. J.C. Allaire, A. Gamaldo, B.J. Ayotte, R. Sims, and K. Whitfield Mild cognitive impairment and objective instrumental everyday functioning: the everyday cognition battery memory test J. Am. Geriatr. Soc. 57 1 2009 Jan 120 125
123. S.C. Allen, M. Jain, S. Ragab, and N. Malik Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects Age Ageing 32 3 2003 May 299 302
124. R.A. Incalzi, A. Gemma, C. Marra, O. Capparella, L. Fuso, and P. Carbonin Verbal memory impairment in COPD: its mechanisms and clinical relevance Chest 112 6 1997 Dec 1506 1513
125. A. Oliviero, G. Corbo, P.A. Tonali, F. Pilato, E. Saturno, M. Dileone, and et al. Functional involvement of central nervous system in acute exacerbation of chronic obstructive pulmonary disease A preliminary transcranial magnetic stimulation study J. Neurol. 249 9 2002 Sep 1232 1236
126. R.K. Heaton, I. Grant, A.J. McSweeny, K.M. Adams, and T.L. Petty Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease Arch. Intern Med. 143 10 1983 Oct 1941 1947
127. J.J. Liesker, D.S. Postma, R.J. Beukema, N.H. ten Hacken, T. van der Molen, R.A. Riemersma, and et al. Cognitive performance in patients with COPD Respir. Med. 98 4 2004 Apr 351 356
128. N. Ambrosino, G. Bruletti, V. Scala, R. Porta, and M. Vitacca Cognitive and perceived health status in patient with chronic obstructive pulmonary disease surviving acute on chronic respiratory failure: a controlled study Intensive Care Med. 28 2 2002 Feb 170 177
129. M.E. Conte, C. Pedone, F. Forastiere, V. Bellia, and R. Antonelli-Incalzi Discriminative and predictive properties of disease-specific and generic health status indexes in elderly COPD patients BMC Pulm. Med. 8 2008 14
130. Y. Salik, S. Ozalevli, and A.H. Cimrin Cognitive function and its effects on the quality of life status in the patients with chronic obstructive pulmonary disease (COPD) Arch. Gerontol. Geriatr. 45 3 2007 Nov-Dec 273 280
131. L.S. Covey, A.H. Glassman, and F. Stetner Depression and depressive symptoms in smoking cessation Compr. Psychiatry 31 4 1990 Jul-Aug 350 354
132. A.H. Glassman, J.E. Helzer, L.S. Covey, L.B. Cottler, F. Stetner, J.E. Tipp, and et al. Smoking, smoking cessation, and major depression JAMA 264 12 1990 Sep 26 1546 1549
133. J. Qian, L. Simoni-Wastila, P. Langenberg, G.B. Rattinger, I.H. Zuckerman, S. Lehmann, and et al. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease J. Am. Geriatr. Soc. 61 5 2013 May 754 761
134. W. Xu, J.P. Collet, S. Shapiro, Y. Lin, T. Yang, R.W. Platt, and et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations Am. J. Respir. Crit. Care Med. 178 9 2008 Nov 1 913 920
135. C.M. Boyd, J. Darer, C. Boult, L.P. Fried, L. Boult, and A.W. Wu Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance JAMA 294 6 2005 Aug 10 716 724
136. A. Stephenson, D.P. Seitz, H.D. Fischer, A. Gruneir, C.M. Bell, A.S. Gershon, and et al. Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study Drugs Aging 29 3 2012 Mar 1 213 223
137. R.A. Incalzi, S. Scarlata, G. Pennazza, M. Santonico, and C. Pedone Chronic obstructive pulmonary disease in the elderly Eur. J. Intern Med. 25 4 2014 Apr 320 328
138. P.L. Enright, R.L. McClelland, A.B. Newman, D.J. Gottlieb, and M.D. Lebowitz Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular health Study research group Chest 116 3 1999 Sep 603 613
139. C.H. Martinez, and M.K. Han Contribution of the environment and comorbidities to chronic obstructive pulmonary disease phenotypes Med. Clin. North Am. 96 4 2012 Jul 713 727
140. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur. Respir. J. 33 5 2009 May 1165 1185
141. M. de Groot, B.F. Verhaaren, R. de Boer, S. Klein, A. Hofman, A. van der Lugt, and et al. Changes in normal-appearing white matter precede development of white matter lesions Stroke 44 4 2013 Apr 1037 1042